Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index; 9 of the 26 sources its claims cite were checked for support.

Effectiveness of synchronous teleconsultation for patients with type 2 diabetes mellitus: a systematic review and meta-analysis

Open access
Zhang, Jianxin, Ji, Xinxin, Xie, Jieying, Lin, Kai, Yao, Mi, Chi, Chunhua · 2023 · BMJ Open Diabetes Research & Care

Abstract

The popularity of teleconsultation during the COVID-19 pandemic enabled increased accessibility for individuals with type 2 diabetes mellitus (T2DM). However, previous studies did not distinguish between synchronous and asynchronous teleconsultation. We evaluated the effectiveness of synchronous teleconsultation for patients with T2DM. We searched Medline, Embase, Cochrane Central Register of Controlled Trials, Cochrane Library and Cochrane Database of Systematic Reviews, ClinicalTrials.gov, and the WHO International Clinical Trials Registry Platform databases from inception to July 2021. All included studies were randomized controlled trials of synchronous teleconsultation for adults with T2DM compared with usual care. Reviewers independently extracted data and used the Cochrane tool to evaluate risk of bias. Meta-analyses were conducted using random-effects models. A pooled mean difference for both HbA1c (%) and body mass index (BMI) (kg/m 2), systolic blood pressure (SBP) (mm Hg), diastolic blood pressure (DBP) (mm Hg), and low density lipoprotein cholesterol (LDL-cholesterol) (mg/dL) were calculated. Patient-reported outcomes, such as depression, medication adherence, and quality of life, were also assessed. A total of 9807 abstracts were identified and 27 trials were included. Synchronous teleconsultation significantly resulted in greater decrease in HbA1c compared with usual care group (n=8746, 0.35, 95% CI 0.20 to 0.49, I 2=73%, p<0.001). No significant effects on BMI (n=699, 0.08 kg/m 2, 95% CI −0.54 to 0.69), SBP (n=5512, 1.32 mm Hg, 95% CI -0.09 to 2.73), DBP (n=2898, 0.17 mm Hg, 95% CI −1.18 to 1.52), or LDL-cholesterol (n=5276, 3.21 mg/dL, 95% CI −1.75 to 8.17) were found. The effect of teleconsultation in improving patient-reported outcomes was uncertain. Thus, synchronous teleconsultation could be an alternative to usual care. Systematic review registration is PROSPERO CRD42021267019.

Overview

CoChat Summary

TL;DR

This systematic review and meta-analysis found that synchronous teleconsultation for adults with type 2 diabetes produced a modestly greater HbA1c reduction than usual care, but did not significantly improve BMI, blood pressure, or LDL-cholesterol. Patient-reported outcomes were uncertain, and the authors conclude synchronous teleconsultation could be an alternative to usual care.

Key findings

  • Among 27 included RCTs (10,019 patients), synchronous teleconsultation significantly reduced HbA1c versus usual care: mean difference 0.35% (95% CI 0.20 to 0.49; I²=73%; p<0.001; n=8746 in the abstract).
  • No significant effects were found for BMI (0.08 kg/m², 95% CI −0.54 to 0.69; n=699), SBP (1.32 mm Hg, 95% CI −0.09 to 2.73; n=5512), DBP (0.17 mm Hg, 95% CI −1.18 to 1.52; n=2898), or LDL-cholesterol (3.21 mg/dL, 95% CI −1.75 to 8.17; n=5276).
  • HbA1c reduction was larger with at least monthly teleconsultation (mean difference 0.67, 95% CI 0.40 to 0.94; I²=79%; p<0.01) than with less than monthly contact (mean difference 0.10, 95% CI −0.04 to 0.24; I²=18%; p=0.30), with a significant subgroup difference (p<0.01).
  • Provider type (p=0.29) and teleconsultation medium (p=0.79) did not significantly differ in HbA1c subgroup analyses. Patient-reported outcomes were uncertain: depression showed no group differences in 2 studies, quality of life showed no differences in 2 studies, and medication adherence showed significant differences in 3 of 4 studies.

Methods

  • Systematic review and random-effects meta-analysis following PRISMA, registered as PROSPERO CRD42021267019; searches covered Medline, Embase, CENTRAL, Cochrane Library, Cochrane Database of Systematic Reviews, ClinicalTrials.gov, and WHO ICTRP from inception to July 2021.
  • Eligible studies were RCTs of adults ≥18 years with T2DM receiving synchronous teleconsultation delivered by health professionals versus usual care; asynchronous teleconsultation and controls using telemedicine were excluded.
  • From 9807 unique abstracts, 27 trials were included; 23 had sufficient non-overlapping HbA1c data for meta-analysis. Reviewers independently extracted data and assessed risk of bias with the Cochrane tool.

Limitations

  • The paper states that included trials were primarily from socially and economically developed areas, limiting generalizability; heterogeneity was significant and not fully explained by prespecified subgroup analyses; and blinding participants or healthcare professionals was impossible, introducing potential bias.
  • The paper also notes that most interventions focused on HbA1c with less attention to BMI, blood pressure, and lipids, and that secondary outcomes used heterogeneous questionnaires, preventing direct between-study comparisons.
  • Evident from the text: 9 of 27 trials had high risk of bias, and the significant heterogeneity (e.g., I²=73% for HbA1c) means pooled estimates should be interpreted cautiously for individual patients.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1136/bmjdrc-2022-003180

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 PRISMA diagram for the literature search. PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-analyses.
Figure 1 PRISMA diagram for the literature search. PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-analyses.CC BY-NC · PubMed Central
Figure 2 Forest plot of comparison: HbA1c, BMI, LDL-cholesterol, DBP, SBP. (A) Forest plot of comparison: HbA1c. (B) Forest plot of comparison: BMI. (C) Forest plot of comparison: LDL-cholesterol. (D) Forest plot of comparison: DBP. (E) Forest plot of comparison: SBP. BMI, body mass index.
Figure 2 Forest plot of comparison: HbA1c, BMI, LDL-cholesterol, DBP, SBP. (A) Forest plot of comparison: HbA1c. (B) Forest plot of comparison: BMI. (C) Forest plot of comparison: LDL-cholesterol. (D) Forest plot of comparison: DBP. (E) Forest plot of comparison: SBP. BMI, body mass index.CC BY-NC · PubMed Central

Verification

Claims the paper makes

5 Valid · 2 Not valid · 13 Not checked · 55 Own results and interpretations

39 more claims

Create a free account to see all 75 claims and to verify the 17 references still open.

See all claims — free account
  • Probably not a substantial claim. 26
  • It may state two separate claims as one. 11
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Show all 45 references

Cited by

See all 22

Metadata

Authors
Zhang, J., Ji, X., Xie, J., Lin, K., Yao, M., & Chi, C.
Affiliations
  • Peking University First Hospital (CN)
  • First Affiliated Hospital of Shantou University Medical College (CN)
  • Nanfang Hospital (CN)
Corresponding author
Chi, Chunhua
Venue
BMJ Open Diabetes Research & Care
Publisher
BMJ
Published
2023-02
Volume
11
Issue
1
Pages
e003180
ISSN
2052-4897 (ISSN-L)
OpenAlex
W4321639006
Cited by
22
References
45
Citations by year
2026: 5 · 2025: 11 · 2024: 5 · 2023: 1
FWCI
1.09
Type
journal article
Language
en
Open access
Locations
  • BMJ Open Diabetes Research & Care (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Peking University (Peking University Baidu Fund 2019BD018)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Telemedicine and Telehealth Implementation
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
type 2 diabetes, telemedicine, HbA1c, glycemic control, blood pressure, LDL cholesterol, body mass index, patient-reported outcomes, medication adherence, quality of life, depression, usual care comparison, COVID-19 pandemic, remote patient monitoring, digital health interventions, risk of bias, risk of bias assessment
MeSH terms
COVID-19, Adult, Diabetes Mellitus, Type 2, Glycated Hemoglobin, Humans, Cholesterol, LDL, Quality of Life, Randomized Controlled Trials as Topic, Remote Consultation, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effectiveness of synchronous teleconsultation for patients with type 2 diabetes mellitus: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.1136/bmjdrc-2022-003180
The paper
Zhang, J., Ji, X., Xie, J., Lin, K., Yao, M., & Chi, C. (2023). Effectiveness of synchronous teleconsultation for patients with type 2 diabetes mellitus: a systematic review and meta-analysis. BMJ Open Diabetes Research & Care. https://doi.org/10.1136/bmjdrc-2022-003180

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.